Comparison and validation of data-mining indices for signal detection: Using the Korean national health insurance claims database

Pharmacoepidemiology and Drug Safety

Volumn 20, Issue 12, 2011, Pages 1278-1286

  Choi, Nam Kyong ^a,b   Chang, Yoosoo ^c   Kim, Ju Young ^d   Choi, Yu Kyong ^e   Park, Byung Joo ^a,b,f  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c School of Medicine   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

^e Department of Internal Medicine   (South Korea)

^f Seoul National University College of Medicine   (South Korea)

Author keywords

Celecoxib; Data mining; Health insurance claims database; Pharmacovigilance; Relative risk

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; DICLOFENAC; IBUPROFEN; KETOPROFEN; PARACETAMOL;

AGED; AMBULATORY CARE; ANGINA PECTORIS; ARTHRALGIA; ARTICLE; BACKACHE; BONE DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DATA MINING; DEEP VEIN THROMBOSIS; GANGRENE; GERIATRIC PATIENT; HEALTH INSURANCE; HEART INFARCTION; HEART PALPITATION; HEART VENTRICLE FIBRILLATION; HOSPITAL ADMISSION; HUMAN; KOREA; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MYALGIA; OSTEOARTHRITIS; PREDICTIVE VALUE; PRESCRIPTION; PRIORITY JOURNAL; REFERENCE DATABASE; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SIGNAL DETECTION; SYNCOPE; SYNOVITIS; TACHYCARDIA; TENDINITIS; THROMBOPHLEBITIS; VALIDATION STUDY; VASCULITIS;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANTI-INFLAMMATORY AGENTS; CYCLOOXYGENASE 2 INHIBITORS; DATA MINING; DATABASES, FACTUAL; HUMANS; ODDS RATIO; OSTEOARTHRITIS; PREDICTIVE VALUE OF TESTS; PYRAZOLES; REPUBLIC OF KOREA; RISK; SENSITIVITY AND SPECIFICITY; SULFONAMIDES;

EID: 82055172257     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2237     Document Type: Article

References (24)

1. Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 2004; 57: 127-34.
2. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001; 10: 483-6.
3. Egberts AC, Meyboom RH, van Puijenbroek EP. Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf 2002; 25: 453-8.
4. Bate A, Lindquist M, Edwards IR, Orre R. A data mining approach for signal detection and analysis. Drug Saf 2002; 25: 393-7.
5. Almenoff J, Tonning JM, Gould AL, Szarfman A, Hauben M, Ouellet-Hellstrom R, Ball R, Hornbuckle K, Walsh L, Yee C, Sacks ST, Yuen N, Patadia V, Blum M, Johnston M, Gerrits C, Seifert H, Lacroix K. Perspectives on the use of data mining in pharmacovigilance. Drug Saf 2005; 28: 981-1007.
6. Hauben M, Zhou X. Quantitative methods in pharmacovigilance: focus on signal detection. Drug Saf 2003; 26: 159-186.
7. van der Heijden PG, van Puijenbroek EP, van Buuren S, van der Hofstede JW. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios. Stat Med 2002; 21: 2027-2044.
8. Hauben M, Madigan D, Gerrits CM, Walsh L, Van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf 2005; 4: 929-948.
9. Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf 2003; 12: 17-29.
10. Wood L, Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf 2004; 27: 871-881.
11. Choi NK, Park BJ. Adverse drug reaction surveillance system in Korea. J Prev Med Pub Health 2007; 40: 278-284.
12. Choi NK, Chang Y, Choi YK, Hahn S, Park BJ. Signal Detection of Rosuvastatin Compared to Other Statins: Data-mining Study Using National Health Insurance Claims Database. Pharmacoepidemiol. Drug Saf 2010; 19: 238-46.
13. Shi S, Klotz U. Clinical use and pharmacological properties of selective COX-2 inhibitors. Eur J Clin Pharmacol 2008; 64: 233-52.
14. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M. Adenoma Prevention with Celecoxib (APC) Study. Investigators.Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005; 352: 1071-80.
15. Malhotra S, Shafiq N, Pandhi P. COX-2 inhibitors: a CLASS act or Just VIGORously promoted. MedGenMed 2004; 23: 6-6.
16. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000;284:1247-55.
17. van Puijenbroek EP, Bate A, Leufkens HG, Lindquist M, Orre R, Egberts AC. A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiol Drug Saf 2002; 11: 3-10.
18. Kubota K, Koide D, Hirai T. Comparison of data mining methodologies using Japanese spontaneous reports. Pharmacoepidemiol Drug Saf 2004; 13: 387-94.
19. Banks D, Woo EJ, Burwen DR, Perucci P, Braun MM, Ball R. Comparing data mining methods on the VAERS database. Pharmacoepidemiol Drug Saf 2005; 14: 601-9.
20. Li C, Xia J, Deng J, Jiang J. A comparison of measures of disproportionality for signal detection on adverse drug reaction spontaneous reporting database of Guangdong province in China. Pharmacoepidemiol Drug Saf 2008; 17: 593-600.
21. Choi NK, Hahn S, Park BJ. Increase in mortality rate following coprescription of cisapride and contraindicated drugs. Ann Pharmacother 2007; 41: 667-673.
22. Pfizer. CELEBREX U.S. Physician Prescribing Information. 27 February 2007. (accessed 20 April 2007).
23. Gould AL. Practical pharmacovigilance analysis strategies. Pharmacoepidemiol Drug Safe 2003; 12: 559-574.
24. Gottlieb S. Opening Pandora's pillbox: using modern information tools to improve drug safety. Health Aff (Millwood) 2005; 24: 938-48.